JCP

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kovács, A
Right arrow Articles by Walker, R A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kovács, A
Right arrow Articles by Walker, R A
Journal of Clinical Pathology 2003;56:139-141
© 2003 BMJ Publishing Group & Association of Clinical Pathologists


SHORT REPORT

P-cadherin as a marker in the differential diagnosis of breast lesions

A Kovács1, R A Walker2

1 Semmelweis Hospital, Department of Pathology, Miskolc PF 187. 3501, Hungary
2 Breast Cancer Research Unit, University of Leicester, Clinical Sciences, Glenfield Hospital, Groby Road, Leicester LE3 9QP, UK

Correspondence to:
Professor R A Walker, Breast Cancer Research Unit, Clinical Sciences, Glenfield Hospital, Groby Road, Leicester LE3 9 QP, UK;
raw14{at}le.ac.uk
ABSTRACT
Aims: To assess the value of the calcium dependent cell adhesion molecule P-cadherin as a myoepithelial marker in the differential diagnosis of benign and malignant breast lesions.

Methods: Immunohistochemical analysis of normal breast, sclerotic breast lesions, tubular carcinomas, and ductal carcinoma in situ using a P-cadherin specific antibody and comparison with smooth muscle actin.

Results: All myoepithelial cells in normal breast ducts, ductules, and lobules and sclerotic lesions showed strong staining for P-cadherin. There was no staining of tubular carcinomas; myoepithelial cells were demonstrated around in situ carcinomas. Weaker reactivity was seen in a proportion of cells in some hyperplasias and in situ carcinomas. This weak reactivity in these tissues was not seen for smooth muscle actin but in radial scars, tubular carcinomas, and ductal carcinoma in situ staining of stromal cells caused difficulties in the identification of myoepithelial cells.

Conclusion: P-cadherin is a useful marker in the differential diagnosis of breast lesions.


Keywords: P-cadherin; breast disease; myoepithelial cell; immunohistochemistry




This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
J. B. Arnes, J.-S. Brunet, I. Stefansson, L. R. Begin, N. Wong, P. O. Chappuis, L. A. Akslen, and W. D. Foulkes
Placental Cadherin and the Basal Epithelial Phenotype of BRCA1-Related Breast Cancer
Clin. Cancer Res., June 1, 2005; 11(11): 4003 - 4011.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pathol.Home page
A Kovacs, J Dhillon, and R A Walker
Expression of P-cadherin, but not E-cadherin or N-cadherin, relates to pathological and functional differentiation of breast carcinomas
Mol. Pathol., December 1, 2003; 56(6): 318 - 322.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Journal of Clinical Pathology Molecular Pathology
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2003 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.